What does HealthCap invest in?
HealthCap invests most often at Series B and Series A (62% of the rounds on record), in sectors such as Life Science, Therapeutics and Rare Diseases.

Sweden · Investor
Last cheque observed Oct 2026; 32 cheques on record.
Deploying nowNew fund $179M, Jan 2024VC firm
Follow HealthCap and see its new cheques in your feed.Start following
1 cheques in the last 12 months
Mostly Series B and Series A: 62% of its rounds
Sole investor in 1 rounds, median $6.8M
5 exits from the portfolio
HealthCap is a life science investor and company creator.From their own website
Every round we can evidence, newest first32 appearances
1 round
1 round
2 rounds
4 rounds
3 rounds
2 rounds
1 round
3 rounds
2 rounds
5 rounds
4 rounds
1 round
2 rounds
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration20 named
We also hold 31 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
From their own portfolio page (on their website)
Adcendo ApSAltay TherapeuticsAprea TherapeuticsAriceum TherapeuticsCurifyLabsDoctrinFusionpharmaGesynta PharmaHelloBetterHemab TherapeuticsIncardatherapeuticsKivu BioscienceMahzi TherapeuticsOncorenaPositrigoPriotheraSpruce BiosciencesAMRA Medical ABBonesupport ABElsa Science ABIntervaccNeobiomicsOncopeptides ABSynOx Therapeutics Ltd
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Companies it backed that were later bought or listed5 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as HealthCap. A count of rooms they were both in, not a relationship either has claimed.
The latest companies HealthCap put money into.
HealthCap invests most often at Series B and Series A (62% of the rounds on record), in sectors such as Life Science, Therapeutics and Rare Diseases.
32 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in Oct 2026.
Its most recent investments on record: Altay Therapeutics, Inc. (Series A, Oct 2026), Hemab Therapeutics (Series B, Feb 2023) and Carisma Therapeutics (Series A, Aug 2019).
The median round it joins is $49M. It says it writes cheques of $100K to $5.0M.
Sometimes: it led 1 of its 32 investments on record (3%).
Most of the companies it backs are in the United States (47%), Sweden (17%) and France (10%).
Yes: it is actively investing, with 1 investments in the last 12 months.
Most often Apax Partners (4 rounds together), Auriga Partners (4 rounds together) and Bay City Capital (3 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it